StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report released on Sunday morning. The firm issued a hold rating on the stock.
TherapeuticsMD Trading Down 1.2 %
TXMD opened at $1.67 on Friday. The business’s 50-day simple moving average is $1.75 and its 200-day simple moving average is $1.93. TherapeuticsMD has a one year low of $1.43 and a one year high of $3.15.
TherapeuticsMD (NASDAQ:TXMD – Get Free Report) last released its quarterly earnings results on Monday, August 12th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.23 million during the quarter.
Institutional Inflows and Outflows
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Featured Articles
- Five stocks we like better than TherapeuticsMD
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Warren Buffett Stocks to Buy Now
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.